The global respiratory care devices market was valued at $22.9 billion in 2023, and is projected to reach $47.9 Billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033
The global metered dose inhalers market was valued at $10.1 billion in 2024, and is projected to reach $18.4 billion by 2034, growing at a CAGR of 6.2% from 2025 to 2034.
